These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29914349)

  • 1. Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1.
    Pierpont EI; Hudock RL; Foy AM; Semrud-Clikeman M; Pierpont ME; Berry SA; Shanley R; Rubin N; Sommer K; Moertel CL
    J Neurodev Disord; 2018 Jun; 10(1):21. PubMed ID: 29914349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome.
    McNeill AM; Hudock RL; Foy AMH; Shanley R; Semrud-Clikeman M; Pierpont ME; Berry SA; Sommer K; Moertel CL; Pierpont EI
    Am J Med Genet A; 2019 Dec; 179(12):2433-2446. PubMed ID: 31566897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention skills and executive functioning in children with Noonan syndrome and their unaffected siblings.
    Pierpont EI; Tworog-Dube E; Roberts AE
    Dev Med Child Neurol; 2015 Apr; 57(4):385-92. PubMed ID: 25366258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social behavior in RASopathies and idiopathic autism.
    Foy AMH; Hudock RL; Shanley R; Pierpont EI
    J Neurodev Disord; 2022 Jan; 14(1):5. PubMed ID: 35021989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social skills of children with neurofibromatosis type 1.
    Barton B; North K
    Dev Med Child Neurol; 2004 Aug; 46(8):553-63. PubMed ID: 15287247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.
    Haebich KM; Pride NA; Walsh KS; Chisholm A; Rouel M; Maier A; Anderson V; Barton B; Silk T; Korgaonkar M; Seal M; Lami F; Lorenzo J; Williams K; Dabscheck G; Rae CD; Kean M; North KN; Payne JM
    BMJ Open; 2019 Sep; 9(9):e030601. PubMed ID: 31558455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Language in young children with neurofibromatosis-1: relations to functional communication, attention, and social functioning.
    Brei NG; Klein-Tasman BP; Schwarz GN; Casnar CL
    Res Dev Disabil; 2014 Oct; 35(10):2495-504. PubMed ID: 24995687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autism spectrum disorder profiles in RASopathies: A systematic review.
    Debbaut E; Steyaert J; El Bakkali M
    Mol Genet Genomic Med; 2024 Apr; 12(4):e2428. PubMed ID: 38581124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor impairment in children with Neurofibromatosis type 1: Effect of the comorbidity with language disorders.
    Iannuzzi S; Albaret JM; Chignac C; Faure-Marie N; Barry I; Karsenty C; Chaix Y
    Brain Dev; 2016 Feb; 38(2):181-7. PubMed ID: 26321374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mediating role of ADHD symptoms between executive function and social skills in children with neurofibromatosis type 1.
    Haebich KM; Dao DP; Pride NA; Barton B; Walsh KS; Maier A; Chisholm AK; Darke H; Catroppa C; Malarbi S; Wilkinson JC; Anderson VA; North KN; Payne JM
    Child Neuropsychol; 2022 Apr; 28(3):318-336. PubMed ID: 34587865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.
    Walsh KS; Vélez JI; Kardel PG; Imas DM; Muenke M; Packer RJ; Castellanos FX; Acosta MT
    Dev Med Child Neurol; 2013 Feb; 55(2):131-138. PubMed ID: 23163951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The self-concept of children and adolescents with neurofibromatosis type 1.
    Barton B; North K
    Child Care Health Dev; 2007 Jul; 33(4):401-8. PubMed ID: 17584395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions.
    Johnson NS; Saal HM; Lovell AM; Schorry EK
    J Pediatr; 1999 Jun; 134(6):767-72. PubMed ID: 10356149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological features in RASopathies: A pilot study on parent training program involving families of children with Noonan syndrome.
    Montanaro FAM; Alfieri P; Caciolo C; Cumbo F; Piga S; Tartaglia M; Licchelli S; Digilio MC; Vicari S
    Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):510-519. PubMed ID: 36490374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parent-Reported Social Skills in Children with Neurofibromatosis Type 1: Longitudinal Patterns and Relations with Attention and Cognitive Functioning.
    Glad DM; Casnar CL; Yund BD; Lee K; Klein-Tasman BP
    J Dev Behav Pediatr; 2021 Oct-Nov 01; 42(8):656-665. PubMed ID: 34618723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
    Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
    J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social functioning in adults with neurofibromatosis type 1.
    Pride NA; Crawford H; Payne JM; North KN
    Res Dev Disabil; 2013 Oct; 34(10):3393-9. PubMed ID: 23911645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autism Spectrum Disorder Symptom Profile Across the RASopathies.
    Geoffray MM; Falissard B; Green J; Kerr B; Evans DG; Huson S; Burkitt-Wright E; Garg S
    Front Psychiatry; 2020; 11():585700. PubMed ID: 33519543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1.
    Janusz JA; Klein-Tasman BP; Payne JM; Wolters PL; Thompson HL; Martin S; de Blank P; Ullrich N; Del Castillo A; Hussey M; Hardy KK; Haebich K; Rosser T; Toledo-Tamula MA; Walsh KS;
    Neurology; 2021 Aug; 97(7 Suppl 1):S73-S80. PubMed ID: 34230205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.